Lvm-MD-14 Preapmrphase 3Double-Blind
Research payments
$1,794,344
Through program year 2019, $1,794,344 in research payments was reported against Lvm-MD-14 Preapmrphase 3Double-Blind, across 212 payments, paid by Allergan Inc..
- Paid by
- Allergan Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $1,794,344 | 212 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jason Miller Lackland A F B, TX Named on 18 payments
- Michael Greenbaum Libertyville, IL Named on 12 payments
- Gintaras Aukstuolis Little Rock, AR Named on 11 payments
- Matthew MacAluso Wichita, KS Named on 10 payments
- Sherry Soefje Oceanside, CA Named on 8 payments
- Shirin Schilling Farmington, CT Named on 8 payments
- Sarah Atkinson Rochester, NY Named on 8 payments
- Riaz Baber Naperville, IL Named on 7 payments
- Rodney Kreider Stockbridge, GA Named on 7 payments
- Louise Thurman Oklahoma City, OK Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.